💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadExplore for free

BRIEF-Bausch Health Says Not Going To Take Price Increases On U.S. Drugs For Rest Of Year

Published 2018-08-07, 09:20 a/m
© Reuters.  BRIEF-Bausch Health Says Not Going To Take Price Increases On U.S. Drugs For Rest Of Year
BHC
-

Aug 7 (Reuters) - Bausch Health Companies Inc BHC.TO BHC.N :

* BAUSCH HEALTH CEO SAYS NEW EYE DRUG LUMIFY ACHIEVED 21 PERCENT MARKET SHARE IN REDNESS RELIEVER CATEGORY- CONF. CALL

* BAUSCH HEALTH SAYS SINCE THE FIRST QUARTER 2016, HAVE REDUCED THE COMPANY'S DEBT BY ABOUT $7 BILLION- CONF CALL

* BAUSCH HEALTH SAYS XIFAXAN SALES $294 MILLION IN THE QUARTER, UP 26 PERCENT OVER Q2 OF 2017 - CONF CALL

* BAUSCH HEALTH SAYS WILL CONTINUE TO USE AVAILABLE CASH TO REPAY DEBT- CONF CALL

* BAUSCH HEALTH SAYS DERMATOLOGY BUSINESS CONTINUES TO FACE CHALLENGES FROM AGGRESSIVENESS OF THIRD-PARTY PAYERS AND FROM THE LIMITING OR BLOCKING OF REIMBURSEMENTS - CONF CALL

* BAUSCH HEALTH SAYS EXPECTING VYZULTA ACCESS TO MEDICARE PART D IN 2019 - CONF CALL

* BAUSCH HEALTH SAYS COMPLETED 6 REFINANCING TRANSACTIONS, RAISING TOTAL OF MORE THAN $16 BILLION IN TERM LOANS, UNSECURED BONDS AND SECURED BONDS - CONF. CALL

* BAUSCH HEALTH SAYS NOT GOING TO TAKE ANY PRICE INCREASES ON U.S. BRANDED PRESCRIPTION DRUGS FOR REST OF THE YEAR- CONF. CALL

* BAUSCH HEALTH SAYS INTERNATIONAL PHARMA BUSINESS IS AN AREA OF FOCUS, NOT SATISFIED WITH PERFORMANCE IN SOME GEOGRAPHIES- CONF. CALL

* BAUSCH HEALTH SAYS WILL KEEP OUR PRICING TO SINGLE DIGIT PRICING- CONF. CALL

* BAUSCH HEALTH SAYS ABOUT 47 PERCENT OF BUSINESS NOT EXPOSED TO PRICING PRESSURES- CONF. CALL

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.